Table 4.

Distribution of UGT2B17 genotypes by sex and risk of lung adenocarcinoma

UGT2B17 genotypeCases (%)Controls (%)OR (95% CI)*
Men
    (+/+)36 (52)176 (47)Reference
    (+/0)26 (37)156 (42)0.7 (0.4-1.3)
    (0/0)8 (11)41 (11)0.9 (0.4-2.3)
    (+/+) + (+/0)62 (89)332 (89)Reference
    (0/0)8 (11)41 (11)1.0 (0.4-2.3)
Women
    (+/+)40 (49)161 (50)Reference
    (+/0)26 (32)131 (40)0.7 (0.4-1.4)
    (0/0)15 (19)32 (10)2.4 (1.01-5.7)
    (+/+) + (+/0)66 (81)292 (90)Reference
    (0/0)15 (19)32 (10)2.8 (1.2-6.3)
  • * OR and 95% CI adjusted for age, BMI, education level, and pack-years.